Drug Database
Back to search

Netherlands· NL-e67b14cd391e

Ristaben 50 mg, filmomhulde tablet

A sitagliptin product containing sitagliptinefosfaat 1-water, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 19 of our 19 countries.

ATC A10BH01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRistaben 50 mg, filmomhulde tabletATCA10BH01REGISTER NO.NL-e67b14cd391ePACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sitagliptinefosfaat 1-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sitagliptin is registered in 19 of 19 countries.

Countries holding a registration under ATC A10BH01 (sitagliptin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 11 of them publish a price we can compare per daily dose
Search sitagliptin products by name

Sitagliptin · ATC A10BH01

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sitagliptin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.65 in France to $5.47 in Switzerland — a ×8.4 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sitagliptin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$5.47
  • IT Italy$1.78
  • ES Spain$1.08
  • FR France$0.65
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SITAGLIPTINEFOSFAAT 1-WATER
Manufacturer
Merck Sharp & Dohme B.V.
Country
Netherlands (NL)
ATC code
A10BH01
ATC class
Sitagliptin
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/10/621

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

341 interactions on record for sitagliptin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sitagliptin against other medicinesHow interaction checks work

Sitagliptin · interactions on record

341 records

  • 3 severe
  • 292 moderate
  • 44 minor

Most severe, free to view

  • GatifloxacinJ01MA16severe
  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sitagliptin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sitagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Jansitin, Jazeta
  • Belgium · Sitagliptin Eg, Sitagliptin Grindeks
  • Bulgaria · Sitagliptin Grindeks, Майсиглу
  • Cyprus · Jidinum, Jimandin
  • Czechia · Anau, Ansifora
  • Germany · Frekidir, Jansitin
  • Denmark · Frekidir, Meliglix
  • Estonia · Adimuplan, Maysiglu
  • Spain · Altuxerin, Disit
  • Finland · Sitagliptin Apc Instytut, Sitagliptin Ashcure
  • France · Sitagliptine Adamed, Sitagliptine Almus
  • United Kingdom (Northern Ireland) · Sitagliptin, Sitagliptin Amarox
  • Greece · Adimuplan, Axavel
  • Croatia · Adimuplan, Condias
  • Hungary · Ansifora, Jaglix
  • Ireland · Sitagliptin Grindeks, Sitagliptin Krka
  • Iceland · Januvia, Ristaben
  • Italy · Adaglip, Andamane
  • Liechtenstein · Januvia, Ristaben
  • Lithuania · Adimuplan, Jimandin
  • Luxembourg · Sitagliptin Eg
  • Latvia · Adimuplan, Jimandin
  • Malta · Anau, Jidinum
  • Norway · Frekidir, Januvia
  • Poland · Ansifora, Jansitin
  • Portugal · Itam, Jidinum
  • Romania · Adimuplan, Jansitin
  • Sweden · Axavel, Frekidir
  • Slovenia · Adimuplan, Maysiglu
  • Slovakia · Adimuplan, Anau

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a9ec84f2-ac9f-4f16-b726-2579cfb17e20
GET /v1/drugs/a9ec84f2-ac9f-4f16-b726-2579cfb17e20?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ristaben-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Sitagliptin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp106209",
  "excipients": [
    "CALCIUMDIWATERSTOFFOSFAAT 0-WATER",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMSTEARYLFUMARAAT",
    "POLYVINYLALCOHOL (E 1203)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "SITAGLIPTINEFOSFAAT 1-WATER"
  ],
  "leaflet_url": null,
  "authorised_at": "2010/03/15",
  "procedure_number": "EMEA/H/C/001234",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/10/621",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about sitagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console